Literature DB >> 1384902

Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor.

C Shimazaki1, N Oku, E Ashihara, K Okawa, H Goto, T Inaba, K Ito, N Fujita, H Tsuji, S Murakami.   

Abstract

We developed an effective method for harvesting large numbers of peripheral blood stem cells (PBSC) for use in autotransplantation. Twenty patients with hematological malignancies were treated with high doses of Ara-C (12 g/m2) and VP-16/aclarubicin followed by administration of rhG-CSF (50 micrograms/m2). The optimal time for starting PBSC collection was determined by monitoring the CD34-positive stem cells in blood using immunomagnetic beads. PBSC were collected with a CS-3000 blood cell separator. A total blood volume between 7000 and 9000 ml was processed in each apheresis. Under these conditions, a total of 64 apheresis procedures was performed in the 20 patients. The mean numbers of mononuclear cells and of CFU-GM harvested per apheresis were 4.1 x 10(8)/kg and 110 x 10(4)/kg, respectively. A number of CFU-GM sufficient for engraftment (> 30 x 10(4)/kg) could be harvested by a single apheresis in 15 of the 20 patients. So far, 11 patients have been transplanted with PBSC and obtained rapid hematopoietic recovery. The median time to recover neutrophils more than 0.5 x 10(9)/l was 10 days, and that for platelets 50 x 10(9)/l was 11 days. This method for harvesting large numbers of PBSC allows safer autotransplantation in patients with chemoradiosensitive tumors, and is applicable to older patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384902

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

1.  Long-term survival and late-onset complications of cancer patients treated with high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation.

Authors:  K Kohda; S Sakamaki; T Matsunaga; T Kuga; A Fujimi; Y Konuma; T Kusakabe; K Kogawa; T Akiyama; K Koike; Y Hirayama; Y Sasagawa; S Nojiri; Y Hirata; T Nishisato; G Y Niitsu
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

Review 2.  Autologous bone marrow and peripheral blood stem cell transplantation in haematological malignancies: current status.

Authors:  G Marcoullis; J Mehta; J Treleaven
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064

3.  Effect of continuous subcutaneous administration of a low dose of G-CSF on stem cell mobilization in healthy donors: a feasibility study.

Authors:  Junko Tanaka; Takaaki Miyake; Tadashi Shimizu; Toshio Wakayama; Michihiro Tsumori; Kunio Koshimura; Yoshio Murakami; Yuzuru Kato
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

Review 4.  Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia.

Authors:  J E Frampton; C R Lee; D Faulds
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

5.  Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer.

Authors:  P Pedrazzoli; C Perotti; G A Da Prada; F Bertolini; N Gibelli; L Torretta; M Battaglia; L Pavesi; P Preti; L Salvaneschi; G Robustelli della Cuna
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.